HIV POLYPROTEIN IMMUNOGENS

The present invention relates to HIV polyprotein immunogens that find application as diagnostic reagents in the detection of HIV infection, as prophylactic or interventive vaccines against HIV infection, and as therapeutic agents in the treatment of HIV-I infection. Specifically, the present inventi...

Full description

Saved in:
Bibliographic Details
Main Authors SMITH, GALE, E, VOLVOVITZ, FRANKLIN, KNELL, JOHN, D, DEBARTOLOMEIS, JAMES, HACKETT, CRAIG, S
Format Patent
LanguageEnglish
French
Published 30.11.1995
Edition6
Subjects
BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPIRITS
VINEGAR
WINE
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to HIV polyprotein immunogens that find application as diagnostic reagents in the detection of HIV infection, as prophylactic or interventive vaccines against HIV infection, and as therapeutic agents in the treatment of HIV-I infection. Specifically, the present invention relates to the HIV polyprotein immunogens, gp160/p24 and gp160/p55. Immunogènes de polyprotéines de VIH, utilisés comme réactifs diagnostiques pour la détection d'une infection à VIH, comme vaccins ou prophylactiques contre l'infection à VIH, et comme agents thérapeutiques dans le traitement de l'infection à VIH-I. La présente invention se rapporte spécifiquement aux immunogènes de polyprotéines de VIH gp160/p24 et gp160/p55.
Bibliography:Application Number: WO1995US06346